These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2198387)

  • 21. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
    Selenkow HA; Wyman P; Allweiss P
    Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
    Meshaka G; Jacquillat C; Sultan Y
    Presse Med (1893); 1967 Jul; 75(32):1653-5. PubMed ID: 6067478
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune function in children born to mothers with autoimmune diseases and exposed in utero to immunosuppressants.
    Biggioggero M; Borghi MO; Gerosa M; Trespidi L; Cimaz R; Meroni PI
    Lupus; 2007; 16(8):651-6. PubMed ID: 17711903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoimmune dermatoses: new therapeutic strategies].
    Trüeb RM
    Praxis (Bern 1994); 2000 Sep; 89(37):1460-7. PubMed ID: 11037617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciamexone, a highly selective immunomodulator--a tool for autoimmune diseases?
    Bicker U; Usadel KH
    Klin Wochenschr; 1986 Dec; 64(24):1261-6. PubMed ID: 3493387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current status of immunosuppressive therapy in non-neoplastic disorders].
    Grob PJ
    Schweiz Med Wochenschr; 1970 Apr; 100(16):703-7. PubMed ID: 4946733
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical immunotoxicity of antirheumatic drugs.
    Bálint G; Gergely P
    Inflamm Res; 1996 Dec; 45 Suppl 2():S91-5. PubMed ID: 8988409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pentostatin (Nipent) and high-dose cyclophosphamide for the treatment of refractory autoimmune disorders.
    Goodman M
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):67-71. PubMed ID: 10877056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in immunosuppressive drug therapy for use in autoimmune disease and systemic vasculitis.
    Marder W; McCune WJ
    Semin Respir Crit Care Med; 2004 Oct; 25(5):581-94. PubMed ID: 16088501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term complications of conventional immunosuppressive treatment.
    Boitard C; Bach JF
    Adv Nephrol Necker Hosp; 1989; 18():335-54. PubMed ID: 2493723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Medicamental immunosuppression in dermatology (author's transl)].
    Goerz G; Merk H
    Z Hautkr; 1981 Aug; 56(15):975-90. PubMed ID: 7269720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for the control of host defenses.
    Howard RJ
    Surgery; 1982 Aug; 92(2):138-45. PubMed ID: 6179173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chronic autoimmune thyroiditis and connective tissue system diseases].
    Macejová Z; Benhatchi K; Lazúrová I
    Vnitr Lek; 2006 Sep; 52(9):801-4. PubMed ID: 17091604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease.
    Bach JF
    C R Biol; 2006 Apr; 329(4):260-2. PubMed ID: 16644496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The current and future outlook in immunosuppressive therapy for children].
    Goţia S; Ionescu C
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):35-42. PubMed ID: 9524654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutics. XI. Immunosuppressive drugs.
    Ashton H; Beveridge GW; Stevenson CJ
    Br J Dermatol; 1970 Aug; 83(2):326-30. PubMed ID: 4916789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.